Statistics
Publications
4
Citations
616
H-Index
4
Active since
2017
Mei Zeng is an author at Harvard University specializing in kras g12c inhibition, molecular oncology, and medicinal chemistry.
Publications per year
2017–2019
4
4
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng, Yuan Xiong, Nozhat Safaee et al. · Cell chemical biology · 2019 · 275 citations · Full text
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng, Nicholas Kwiatkowski, Tinghu Zhang et al. · eLife · 2018 · 166 citations · Full text
Medicine, Cancer Biology, Oncology +17
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
Mei Zeng, Jia Lu, Lianbo Li et al. · Cell chemical biology · 2017 · 137 citations · Full text
1–4 of 4